CLINICAL_TRIALS
trial_result
· 2019-12-27
Clinical Trial Update: Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome [Phase 2]
Summary
Phase 2 trial evaluating lubiprostone for adults with mixed or unsubtyped irritable bowel syndrome was terminated with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sucampo Pharma Americas, LLC | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2019-12-27